Applied Clinical Trials
April 10, 2020
29
4
Industry experts weigh in on how much traditional approaches in clinical operations need to change to meet new expectations for clinical delivery.
April 10, 2020
29
4
Lockstep with regulatory guidance on conducting trials amid crisis, here are four key actions sponsors can take to minimize disruptions.
April 01, 2020
29
4
Click the title above to open the Applied Clinical Trials April 2020 issue in an interactive PDF format.
April 01, 2020
29
4
COVID-19 will not only leave a long legacy on public health, but it may also force companies that have been lagging behind the disruption curve to adopt technologies and processes that will make clinical trials more efficient.
April 01, 2020
29
4
That question will likely hinge on EFPIA's ability to uphold its commitment to "work with governments and health systems to ensure that when new treatments and vaccines are approved, they are available and affordable.”
April 01, 2020
29
4
Expert in rare disease patient registries discusses ways to address hurdles in setting up observational cohort clinical studies.
April 01, 2020
29
4
A compilation of recent notable news developments that pertain to the clinical trials industry.
April 01, 2020
29
4
Outlining the three concerns communicated the most when it comes to implementing an FSP outsourcing strategy.
April 01, 2020
29
4
Examining the advantages of a program-wide data strategy in advancing high-efficiency drug development.
April 01, 2020
29
4
New agency initiatives aim is to fully reflect the impact of treatment on patients representing a range of ages, ethnic backgrounds, and other demographic features